Brendan Smith
Stock Analyst at TD Cowen
(4.68)
# 784
Out of 4,520 analysts
265
Total ratings
53.6%
Success rate
18.8%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Maintained: Buy | $365 → $410 | $360.40 | +13.76% | 6 | Jul 15, 2026 | |
| EVO Evotec SE | Downgraded: Hold | $4 → $2 | $1.99 | +0.50% | 10 | Jul 15, 2026 | |
| EVT Eaton Vance Tax-Advantaged Dividend Income Fund | Downgraded: Hold | n/a | $26.97 | - | 1 | Jul 14, 2026 | |
| SLP Simulations Plus | Maintained: Hold | $16 | $18.25 | -12.33% | 5 | Jul 9, 2026 | |
| TWST Twist Bioscience | Rated: Buy | $68 → $89 | $87.10 | +2.18% | 17 | Jun 15, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | n/a | $2.02 | - | 7 | May 27, 2026 | |
| MXCT MaxCyte | Maintained: Buy | n/a | $1.33 | - | 11 | May 12, 2026 | |
| PASG Passage Bio | Reiterated: Hold | n/a | $4.91 | - | 10 | May 12, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $96 | $78.96 | +21.58% | 23 | May 11, 2026 | |
| CERT Certara | Rated: Buy | $10 → $9 | $7.25 | +24.14% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.08 | - | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $2.14 | -6.48% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $30.50 | +8.20% | 11 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $7.97 | +50.56% | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.78 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.61 | +8.46% | 11 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.03 | +47.78% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $20 | $26.35 | -24.10% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.27 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.96 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.23 | +33.84% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $148.12 | +35.03% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $15.42 | +29.70% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $72.99 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.28 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $9 | $8.16 | n/a | 6 | Nov 12, 2024 |
West Pharmaceutical Services
Jul 15, 2026
Maintained: Buy
Price Target: $365 → $410
Current: $360.40
Upside: +13.76%
Evotec SE
Jul 15, 2026
Downgraded: Hold
Price Target: $4 → $2
Current: $1.99
Upside: +0.50%
Eaton Vance Tax-Advantaged Dividend Income Fund
Jul 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $26.97
Upside: -
Simulations Plus
Jul 9, 2026
Maintained: Hold
Price Target: $16
Current: $18.25
Upside: -12.33%
Twist Bioscience
Jun 15, 2026
Rated: Buy
Price Target: $68 → $89
Current: $87.10
Upside: +2.18%
Rapid Micro Biosystems
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $2.02
Upside: -
MaxCyte
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.33
Upside: -
Passage Bio
May 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.91
Upside: -
Halozyme Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $96
Current: $78.96
Upside: +21.58%
Certara
May 11, 2026
Rated: Buy
Price Target: $10 → $9
Current: $7.25
Upside: +24.14%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.08
Upside: -
May 7, 2026
Maintained: Hold
Price Target: $2
Current: $2.14
Upside: -6.48%
May 7, 2026
Maintained: Buy
Price Target: $33
Current: $30.50
Upside: +8.20%
May 7, 2026
Maintained: Buy
Price Target: $12
Current: $7.97
Upside: +50.56%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.78
Upside: -
May 7, 2026
Maintained: Hold
Price Target: $5
Current: $4.61
Upside: +8.46%
May 7, 2026
Maintained: Buy
Price Target: $3
Current: $2.03
Upside: +47.78%
May 6, 2026
Maintained: Hold
Price Target: $30 → $20
Current: $26.35
Upside: -24.10%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $7.27
Upside: -
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $2.96
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $5.23
Upside: +33.84%
May 5, 2026
Maintained: Buy
Price Target: $200
Current: $148.12
Upside: +35.03%
May 5, 2026
Maintained: Buy
Price Target: $20
Current: $15.42
Upside: +29.70%
May 13, 2025
Maintained: Buy
Price Target: n/a
Current: $72.99
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: n/a
Current: $23.28
Upside: n/a
Nov 12, 2024
Maintained: Hold
Price Target: $14 → $9
Current: $8.16
Upside: n/a